175 related articles for article (PubMed ID: 11525094)
21. Hepatitis-B vaccination.
Phadke A; Kale A
J Indian Med Assoc; 2004 May; 102(5):270. PubMed ID: 15636033
[No Abstract] [Full Text] [Related]
22. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
Mele A; Stroffolini T; Zanetti AR
J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
[TBL] [Abstract][Full Text] [Related]
24. [Confusing games of public insurance with hepatitis B vaccinations. Interview by Dr. rer. nat. Anita Schweiger].
Eichhorn R
Fortschr Med; 1997 Apr; 115(10):41. PubMed ID: 9206686
[No Abstract] [Full Text] [Related]
25. [Updated STIKO vaccination recommendations published].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2013 Sep; 36(9):317. PubMed ID: 24069644
[No Abstract] [Full Text] [Related]
26. Hepatitis B vaccination coverage among U.S. adolescents, National Immunization Survey-Teen, 2006.
Jain N; Hennessey K
J Adolesc Health; 2009 Jun; 44(6):561-7. PubMed ID: 19465320
[TBL] [Abstract][Full Text] [Related]
27. [Coverage of vaccination against hepatitis B in Poland in 2004].
Magdzik W; Czarkowski MP
Przegl Epidemiol; 2006; 60(2):185-92. PubMed ID: 16964668
[TBL] [Abstract][Full Text] [Related]
28. Preparing for the next public debate: universal vaccination against hepatitis B.
Houweling H; Spaendonck MC; Paulussen T; Verweij M; Ruitenberg EJ
Vaccine; 2011 Nov; 29(48):8960-4. PubMed ID: 21945254
[TBL] [Abstract][Full Text] [Related]
29. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
Wu GY; Gong YL; Yu SL; Shao RT; Qin HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):474-8. PubMed ID: 15231120
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B immunization policy for India.
Aggarwal R; Naik SR
J Assoc Physicians India; 1996 Feb; 44(2):150. PubMed ID: 10999079
[No Abstract] [Full Text] [Related]
31. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
Oldfield EC; Keeffe EB
Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
[TBL] [Abstract][Full Text] [Related]
32. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
Keystone JS; Hershey JH
Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
[TBL] [Abstract][Full Text] [Related]
33. Integration of hepatitis B vaccination into national immunisation programmes. Alternative strategies must be considered before universal vaccination is adopted.
Dunn J; Shukla R; Neal K
BMJ; 1997 Jul; 315(7100):121-2. PubMed ID: 9240065
[No Abstract] [Full Text] [Related]
34. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
Van Damme P; Vorsters A
J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
[TBL] [Abstract][Full Text] [Related]
35. [Vaccination against hepatitis B and epidemiological situation of this disease in European countries in the years 1990-2001].
Magdzik W
Przegl Epidemiol; 2006; 60(2):179-84. PubMed ID: 16964667
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of the efficacy of the national immunization programme for hepatitis B.
Rubin L; Hefer E; Dubnov Y; Warman S; Rishpon S
Public Health; 2007 Jul; 121(7):529-33. PubMed ID: 17320126
[TBL] [Abstract][Full Text] [Related]
37. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
38. The impact of state policies on vaccine coverage by age 13 in an insured population.
Olshen E; Mahon BE; Wang S; Woods ER
J Adolesc Health; 2007 May; 40(5):405-11. PubMed ID: 17448397
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with hepatitis B virus immunization coverage at the beginning of a population campaign in the Lazio region, Italy.
Faustini A; Spadea T; Fano V; Giorgi Rossi P; Sangalli M; Franco E; Perucci CA
Prev Med; 2001 Nov; 33(5):409-14. PubMed ID: 11676581
[TBL] [Abstract][Full Text] [Related]
40. Progress in the prevention and control of viral hepatitis type B: closing remarks.
Rizzetto M; Zanetti AR
J Med Virol; 2002 Jul; 67(3):463-6. PubMed ID: 12116047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
